Document is current

Any future updates will be listed below

898 Triple therapy (binimetinib, bevacizumab, pembrolizumab) modulates the tumor immune microenvironment in microsatellite stable colorectal cancer PDXs in a humanized mice model

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0898

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark